AURINIA PHARMACEUTICALS INC's ticker is and the CUSIP is 05156V902. A total of 5 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,900,000 | -3.7% | 643,500 | +2.5% | 1.85% | +43.6% |
| Q3 2020 | $9,243,000 | -20.6% | 627,500 | -12.4% | 1.29% | -0.8% |
| Q2 2020 | $11,646,000 | +17.4% | 716,700 | +4.9% | 1.30% | -19.4% |
| Q1 2020 | $9,918,000 | -5.9% | 683,500 | +31.4% | 1.61% | -24.7% |
| Q4 2019 | $10,535,000 | – | 520,000 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 617,600 | $4,644,000 | 0.01% |
| SIMPLEX TRADING, LLC | 234,900 | $1,766,000 | 0.00% |
| JANE STREET GROUP, LLC | 292,900 | $2,203,000 | 0.00% |
| JPMORGAN CHASE & CO | 87,300 | $656,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |